A novel formulation strategy for skin occlusion: Semi-solid lipid nanoparticles

Abstract

Lipid nanoparticles (SLNs and NLCs) have possessed many advantages as versatile and innovative carriers to achieve better quality and highly effective skin-care cosmeceuticals. While they protect the water content of the epidermis by increasing skin occlusion, maintain the smoothness and elasticity of the skin, enhance the efficacy of the active substance by penetrating into the deep layers of the skin. Semi-solid lipid nanoparticles, which are the latest generation of lipid nanoparticles containing high amount of lipids compared to SLNs and NLCs are promising systems as nano-cosmeceuticals due to their semi-solid consistency and colloidal particle size. In this study, semi-solid lipid nanoparticles in NLC form were obtained by using different vegetable oils that possess positive effects in the dermal application. Then, the main in vitro physicochemical characteristics of the formulations that affect skin hydration like size, surface charge, and occlusive properties were investigated. Overall results suggested that, while vegetable oil loaded semi-solid lipid nanoparticles were obtained, colloidal size and semi-solid consistency could be maintained. On the other hand, all formulations had acceptable firmness values for customer use despite the high lipid content of the system, and enhanced skin hydration with the help of both vegetable oils and lipid nanoparticles were achieved.

Keywords

• Semi-solid lipid nanoparticles
• nano-cosmeceuticals
• vegetable oil
• skin occlusion.

References

1. [1] Verdier‐Sévrain S, Bonté F. Skin hydration: A review on its molecular mechanisms. J Cosmet Dermatol. 2007; 6(2): 75-82. [CrossRef]
2. [2] Elias PM. Structure and function of the stratum corneum extracellular matrix. J Invest Dermatol. 2012; 132(9): 2131-2133. [CrossRef]
3. [3] Menon GK, Cleary GW, Lane ME. The structure and function of the stratum corneum. Int J Pharm. 2012; 435(1): 3-9. [CrossRef]
4. [4] Choi EH. Aging of the skin barrier. Clin Dermatol. 2019; 37(4): 336-345. [CrossRef]
5. [5] Kammeyer A, Luiten RM. Oxidation events and skin aging. Ageing Res Rev. 2015; 21: 16-29. [CrossRef]
6. [6] Draelos ZD. Cosmeceuticals: Undefined, unclassified, and unregulated. Clin Dermatol. 2009; 27(5): 431-434. [CrossRef]
7. [7] Kilgman AM. Cosmeceuticals: A broad-spectrum category between cosmetics and drugs. In: Elsner P, Maibach H, (Eds.) Cosmeceuticals and Active Cosmetics: Drug versus Cosmetics. CRS press Tylor and Francis Group, 2005, pp.1-9.
8. [8] Lohani A, Verma A, Joshi H, Yadav N, Karki N. Nanotechnology-based cosmeceuticals. Int Sch Res Notices. 2014. Article ID 843687. [CrossRef]

9. [9] Badilli U, Gumustas M, Uslu B, Ozkan SA. Lipid-based nanoparticles for dermal drug delivery. In Grumezescu AM. (Ed.) Organic Materials as Smart Nanocarriers for Drug Delivery. William Andrew Publishing, Chennai, India, 2018, pp. 369-413.
10. [10] Garcês A, Amaral MH, Lobo JS, Silva AC. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review. Eur J Pharm Sci. 2018; 112: 159-167. [CrossRef]
11. [11] Kaul S, Gulati N, Verma D, Mukherjee S, Nagaich U. Role of nanotechnology in cosmeceuticals: A review of recent advances. J Pharm. 2018; Article ID 3420204. [CrossRef]
12. [12] Lippacher A, Müller RH, Mäder K. Semisolid SLN™ dispersions for topical application: Influence of formulation and production parameters on viscoelastic properties. Eur J Pharm Biopharm. 2002; 53(2): 155-160. [CrossRef]
13. [13] Tarimci N, Turk CTS, Badilli U, A novel approach for topical delivery of SLNs: Semisolid SLNs, First ed., Lap LambertAcademic Publishing, 2015.
14. [14] Gordillo-Galeano A, Mora-Huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. Eur J Pharm Biopharm. 2018; 133: 285-308. [CrossRef]
15. [15] Rawat MK, Jain A, Singh S. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats. J Pharm Sci. 2011; 100(6): 2406-2417. [CrossRef]
16. [16] Chantaburanan T, Teeranachaideekul V, Chantasart D, Jintapattanakit A, Junyaprasert VB. Effect of binary solid lipid matrix of wax and triglyceride on lipid crystallinity, drug-lipid interaction and drug release of ibuprofen-loaded solid lipid nanoparticles (SLN) for dermal delivery. J Colloid Interface Sci. 2017; 504: 247-256. [CrossRef]
17. [17] Ramasamy TG, Haidar ZS. Layer-by-layer self-assembly of polymeric multi-layers on solid lipid nanoparticles: A comparative study via dynamic light scattering, transmission electron microscope, atomic force microscope and quartz crystal microbalance with dissipation. J Bionanosci. 2011; 5(2): 155-161. [CrossRef]
18. [18] Rabasco Álvarez AM, González Rodríguez ML. Lipids in pharmaceutical and cosmetic preparations. Grasas y Aceites, 2000; 51(1-2): 74-96. [CrossRef]
19. [19] Zheng M, Falkeborg M, Zheng Y, Yang T, Xu X. Formulation and characterization of nanostructured lipid carriers containing a mixed lipids core. Colloids Surf A Physicochem Eng Asp. 2013; 430: 76-84. [CrossRef]
20. [20] Pinto F, de Barros DP, Fonseca LP. Design of multifunctional nanostructured lipid carriers enriched with α-tocopherol using vegetable oils. Ind Crops Prod. 2018; 118: 149-159. [CrossRef]
21. [21] Ali SM, Yosipovitch G. Skin pH: From basic science to basic skin care. Acta Derm. Venereol. 2013; 93(3): 261-269.
22. [22] Abels C, Angelova-Fischer I. Skin Care Products: Age-Appropriate Cosmetics. In: Surber C, Abels C, Maibach H.(Eds). pH of the Skin: Issues and Challenges, Karger Publishers, Basel, 2018, pp.173-182.
23. [23] Teixeira A, Vasconcelos V, Teixeira M, Almeida V, Azevedo R, Torres T, Sousa Lobo JM, Costa PC, Almeida IF. Mechanical properties of topical anti-psoriatic medicines: Implications for patient satisfaction with treatment. AAPS PharmSciTech. 2019; 20(1): 36. [CrossRef]
24. [24] Pawar J, Narkhede R, Amin P. Design and evaluation of topical diclofenac sodium gel using hot melt extrusion technology as a continuous manufacturing process with Kolliphor® P407. AAPS PharmSciTech. 2017; 18: 2303–2315. [CrossRef] [25] Amasya G, Inal O, Sengel-Turk CT. SLN enriched hydrogels for dermal application: Full factorial design study to estimate the relationship between composition and mechanical properties. Chem Phys Lipids. 2020; 228: 104889. [CrossRef]
25. [26] Wissing S, Müller RH. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity - In vivo study. Eur J Pharm Biopharm. 2003; 56(1): 67-72. [CrossRef]
26. [27] Zhai H, Maibach HI. Effects of skin occlusion on percutaneous absorption: An overview. Skin Pharmacol Appl Skin Physiol. 2001; 14(1): 1-10. [CrossRef]
27. [28] Wiechers JW, Souto EB. Delivering actives via solid lipid nanoparticles and nanostructured lipid carriers: Part III, Stability and Efficacy. Cosmetics and Toiletries. 2013; (127)3: 164 -173.
28. [29] De Vringer T. Topical preparation containing a suspension of solid lipid particles. U.S. Patent No. 5,667,800. 16 Sep. 1997.
29. [30] Naeimifar A, Ahmad Nasrollahi S, Samadi A, Talari R, Sajad Ale‐nabi S, Massoud Hossini A, Firooz, A. Preparation and evaluation of anti‐wrinkle cream containing saffron extract and avocado oil. J Cosmet Dermatol. 2020; 19: 2366-2373. [CrossRef]
30. [31] Miklavčič MB, Taous F, Valenčič V, Elghali T, Podgornik M, Strojnik L, Ogrinc N. Fatty acid composition of cosmetic Argan Oil: Provenience and authenticity criteria. Molecules. 2020; 25(18): 4080. [CrossRef]
31. [32] Boateng L, Ansong R, Owusu W, Steiner-Asiedu M. Coconut oil and palm oil’s role in nutrition, health and national development: A review. Ghana Med J. 2016; 50(3): 189-196. [33] Jenning V, Gysler A, Schäfer-Korting M, Gohla S. Vitamin A loaded solid lipid nanoparticles for topical use: Occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm. 2000; 49(3): 211-218. [CrossRef]
32. [34] Souto EB, Wissing SA, Barbosa CM, Müller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 2004; 278(1): 71-77. [CrossRef]